About This Course

An interactive course aimed at healthcare professionals in the United Kingdom who are already familiar with rheumatoid arthritis (RA).

This three-part interactive course will teach you about the disease-modifying antirheumatic drugs (DMARDs) currently in use for RA and any screening precautions and monitoring requirements for them.

This course should take you approximately 60 minutes to complete.

This course has a 2-year expiry date of 3rd April 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.

Learning Objectives

Here are some key learning objectives from this course:

  • Summarise and classify the DMARDs used in clinical practice.

  • Explain the considerations made prior to initiating DMARD therapy, particularly with regard to advanced therapies (biologics and JAK inhibitors).

  • Describe the monitoring requirements for different classes of DMARDs.

  • List the main risks of advanced therapies and outline appropriate steps to mitigate these.

Expert Faculty

This course has been made in close collaboration with:

Course curriculum

    1. Welcome to the Course

    1. Introduction to Precourse Quiz

    2. Precourse Quiz

    1. Conventional DMARDs and Advanced Therapies

    1. Initiating DMARD Therapy

    1. Monitoring Your Patients on DMARDs

    1. Introduction to Final Quiz

    2. Final Quiz

    1. Conclusions and Take-Home Messages

    2. Course Feedback Survey

About this course

  • Free
  • 10 lessons
  • 0 hours of video content

This non-promotional educational course has been commissioned and funded by Bristol Myers Squibb.

IMM-GB-2300029 March 2023.